Cargando…

Conditional Approval Pathways: The “Special” Case of Global Regenerative Medicine Regulation

Detalles Bibliográficos
Autores principales: Smith, James A., Brindley, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314969/
https://www.ncbi.nlm.nih.gov/pubmed/28125919
http://dx.doi.org/10.1089/rej.2017.1932
_version_ 1782508610331344896
author Smith, James A.
Brindley, David A.
author_facet Smith, James A.
Brindley, David A.
author_sort Smith, James A.
collection PubMed
description
format Online
Article
Text
id pubmed-5314969
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-53149692017-03-06 Conditional Approval Pathways: The “Special” Case of Global Regenerative Medicine Regulation Smith, James A. Brindley, David A. Rejuvenation Res Guest Editorial Mary Ann Liebert, Inc. 2017-02-01 2017-02-01 /pmc/articles/PMC5314969/ /pubmed/28125919 http://dx.doi.org/10.1089/rej.2017.1932 Text en © James A. Smith and David A. Brindley, 2017; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Guest Editorial
Smith, James A.
Brindley, David A.
Conditional Approval Pathways: The “Special” Case of Global Regenerative Medicine Regulation
title Conditional Approval Pathways: The “Special” Case of Global Regenerative Medicine Regulation
title_full Conditional Approval Pathways: The “Special” Case of Global Regenerative Medicine Regulation
title_fullStr Conditional Approval Pathways: The “Special” Case of Global Regenerative Medicine Regulation
title_full_unstemmed Conditional Approval Pathways: The “Special” Case of Global Regenerative Medicine Regulation
title_short Conditional Approval Pathways: The “Special” Case of Global Regenerative Medicine Regulation
title_sort conditional approval pathways: the “special” case of global regenerative medicine regulation
topic Guest Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314969/
https://www.ncbi.nlm.nih.gov/pubmed/28125919
http://dx.doi.org/10.1089/rej.2017.1932
work_keys_str_mv AT smithjamesa conditionalapprovalpathwaysthespecialcaseofglobalregenerativemedicineregulation
AT brindleydavida conditionalapprovalpathwaysthespecialcaseofglobalregenerativemedicineregulation